株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

尿路感染症の世界市場予測:医薬品、検査タイプ、症状、エンドユーザー、地域別

Urinary Tract Infections Market - Forecast (2020 - 2025)

発行 IndustryARC 商品コード 422781
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.95円で換算しております。
尿路感染症の世界市場予測:医薬品、検査タイプ、症状、エンドユーザー、地域別 Urinary Tract Infections Market - Forecast (2020 - 2025)
出版日: 2020年03月11日 ページ情報: 英文 120 Pages
概要

当レポートでは、尿路感染症の世界市場について調査し、医薬品、検査タイプ、徴候、エンドユーザー、地域別の詳細な市場動向を分析・予測し、市場の促進・抑制要因や市場の機会・課題、戦略分析や、競合情勢、主要企業のプロファイルなどをまとめています。

第1章 尿路感染症の世界市場:概要

第2章 エグゼクティブサマリー

第3章 超尿路感染症の世界市場:情勢

  • 市場シェア分析
  • 競合分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • トップ5社の財務分析

第4章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • 市場の課題
  • ファイブフォース分析

第5章 尿路感染症の世界市場:戦略分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会分析
  • 製品・市場のライフサイクル分析
  • 供給・流通

第6章 尿路感染症の世界市場:医薬品別

  • ペニシリン、化合物
  • キノロン類
  • セファロスポリン
  • アミノグリコシド抗生物質
  • スルホンアミド
  • アゾール、アムホテリシンB
  • テトラサイクリン
  • ニトロフラン
  • その他

第7章 尿路感染症の世界市場:検査タイプ別

  • 生化学検査
  • 顕微鏡検査
  • フローサイメトリー検査

第8章 尿路感染症の世界市場:症状別

  • 複雑性尿路感染症
  • 再発性尿路感染症
  • 単純性尿路感染症
  • 神経因性膀胱

第9章 尿路感染症の世界市場:エンドユーザー別

  • 病院
  • 臨床機関
  • 在宅ケア
  • 研究
  • 学術

第10章 尿路感染症の世界市場:地域別

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • その他の地域
    • ブラジル
    • その他

第11章 尿路感染症の世界市場:エントロピー

  • 市場拡大
  • 技術進歩
  • 合併・買収・合弁企業
  • 供給・契約

第12章 企業プロファイル

  • Mindray Medical International Limited
  • Urit Medical Electronic Group Co., Ltd.
  • Siemens Healthcare
  • Roche Diagnostics
  • Beckman Coulter, Inc.
  • Sysmex Corporation
  • Arkray, Inc.
  • Acon Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Elektronika Kft.

第13章 付録

目次
Product Code: HCR 0709

Urinary Tract Infections is a test of urine to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease and diabetes. Globally, development of efficient and advanced technology, rise in the awareness among people regarding urinary tract infections, increasing government initiatives across the globe, growing prevalence of kidney diseases and urinary tract infections, rising healthcare expenditure are the prime growth drivers of the urinary tract infections market. In addition, emergence of portable and battery-operated urinary tract infections devices, and increase in adoption of urinary tract infections in emerging economies such as China, India and others, will create new opportunities for the urinary tract infections market. However, higher cost of the research and development, and stringent government regulations are the key restraints for the urinary tract infections market.

Urinary Tract Infections Market

Geographically, North America dominated the urinary tract infections market, with approximately half of the world's procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing aging population, rise in consumer awareness, increasing prevalence of diseases, such as diabetes, kidney diseases, and Urinary Tract Infections (UTI), favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the end-users, clinical laboratories segment has the highest market share in the urinary tract infections market due to higher procedure volumes.

This report identifies the urinary tract infections market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the urinary tract infections market.

This report segments the urinary tract infections market on the basis of drug type, test type, indication, end-user, and regional market as follows:

Urinary Tract Infections Market, By Drug Type: Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides, Azoles and Amphotericin B, Tetracycline, Nitrofurans, and Other

Urinary Tract Infections Market, By Test Type: Biochemical Urinary Tract Infections, Microscopic Urinary Tract Infections, and Flow Cytometric Urinary Tract Infections

The report has focused study on urinary tract infections market by basis of indication such as: Complicated Urinary Tract Infection, Recurring Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection, and Neurogenic Bladder Infections

The report has focused study on urinary tract infections market by basis of end-user such as: Hospitals, Clinical Laboratories, Home Healthcare, Research, and Academics

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the urinary tract infections market. Some of the major companies' profiles in detail are as follows:

Mindray Medical International Limited

Urit Medical Electronic Group Co., Ltd.

Siemens Healthcare (Subsidiary of Siemens AG)

Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.)

Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

1. Urinary Tract Infections Market - Overview

2. Executive Summary

3. Urinary Tract Infections Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Urinary Tract Infections Market- Forces

  • 4.1. Drivers
    • 4.1.1. Development of efficient and advance technology
    • 4.1.2. Growing prevalence of kidney diseases and urinary tract infections
  • 4.2. Restraints
    • 4.2.1. Higher cost of research and development
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Urinary Tract Infections Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Urinary Tract Infections Market, By Drug Type

  • 6.1. Penicillin & Combinations
  • 6.2. Quinolones
  • 6.3. Cephalosporin
  • 6.4. Aminoglycoside Antibiotics
  • 6.5. Sulphonamides
  • 6.6. Azoles and Amphotericin B
  • 6.7. Tetracycline
  • 6.8. Nitrofurans
  • 6.9. Other

7. Urinary Tract Infections Market, By Test Type

  • 7.1. Biochemical Urinary Tract Infections
  • 7.2. Microscopic Urinary Tract Infections
  • 7.3. Flow Cytometric Urinary Tract Infections

8. Urinary Tract Infections Market, By Indication

  • 8.1. Complicated Urinary Tract Infection
  • 8.2. Recurring Complicated Urinary Tract Infection
  • 8.3. Uncomplicated Urinary Tract Infection
  • 8.4. Neurogenic Bladder Infections

9. Urinary Tract Infections Market, By End-User

  • 9.1. Hospitals
  • 9.2. Clinical Laboratories
  • 9.3. Home Healthcare
  • 9.4. Research
  • 9.5. Academics

10. Urinary Tract Infections Market, By Geography

  • 10.1. Europe
    • 10.1.1. Germany
    • 10.1.2. France
    • 10.1.3. Italy
    • 10.1.4. Spain
    • 10.1.5. Russia
    • 10.1.6. U.K.
    • 10.1.7. Rest of Europe
  • 10.2. Asia Pacific
    • 10.2.1. China
    • 10.2.2. India
    • 10.2.3. Japan
    • 10.2.4. South Korea
    • 10.2.5. Rest of Asia-Pacific
  • 10.3. North America
    • 10.3.1. U.S.
    • 10.3.2. Canada
    • 10.3.3. Mexico
  • 10.4. Rest of the World (RoW)
    • 10.4.1. Brazil
    • 10.4.2. Rest of RoW

11. Urinary Tract Infections - Entropy

  • 11.1. Expansion
  • 11.2. Technological Developments
  • 11.3. Merger & Acquisitions, and Joint Ventures
  • 11.4. Supply- Contract

12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 12.1. Mindray Medical International Limited
  • 12.2. Urit Medical Electronic Group Co., Ltd.
  • 12.3. Siemens Healthcare (Subsidiary of Siemens AG)
  • 12.4. Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.)
  • 12.5. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • 12.6. Sysmex Corporation
  • 12.7. Arkray, Inc.
  • 12.8. Acon Laboratories, Inc.
  • 12.9. Bio-Rad Laboratories, Inc.
  • 12.10. Elektronika Kft.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

13. Appendix

  • 13.1. Abbreviations
  • 13.2. Sources
  • 13.3. Research Methodology
  • 13.4. Bibliography
  • 13.5. Compilation of Expert Insights
  • 13.6. Disclaimer